ANDA 73250, held by Velzen Pharma Pvt. Nifedipine.
As of Nov 16, 2026, ANDA 73250 (Nifedipine), held by Velzen Pharma Pvt, was first approved by FDA on Oct 8, 1991, with 8 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 8, 1991 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Nifedipine10MG · capsule;oral | Nifedipine | Rx |
| May 21, 2018 | Supplement 10Labeling · Standard review | Approved | None posted |
| Jun 19, 2001 | Supplement 7Manufacturing | Approved | None posted |
| Dec 31, 1998 | Supplement 6Manufacturing | Approved | None posted |
| Jun 12, 1998 | Supplement 5Labeling | Approved | None posted |
| Jan 24, 1997 | Supplement 4Labeling | Approved | None posted |
| Jul 31, 1996 | Supplement 2Manufacturing | Approved | None posted |
| Jul 26, 1996 | Supplement 3Labeling | Approved | None posted |
| Mar 24, 1992 | Supplement 1Labeling | Approved | None posted |
| Oct 8, 1991 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters